Watanabe, M.; Sato, T.; Yano, T.; Higashide, M.; Ogawa, T.; Nishikiori, N.; Furuhashi, M.; Ohguro, H.
mTOR Inhibitors Modulate the Biological Nature of TGF-β2-Treated or -Untreated Human Trabecular Meshwork Cells in Different Manners. Biomedicines 2024, 12, 2604.
https://doi.org/10.3390/biomedicines12112604
AMA Style
Watanabe M, Sato T, Yano T, Higashide M, Ogawa T, Nishikiori N, Furuhashi M, Ohguro H.
mTOR Inhibitors Modulate the Biological Nature of TGF-β2-Treated or -Untreated Human Trabecular Meshwork Cells in Different Manners. Biomedicines. 2024; 12(11):2604.
https://doi.org/10.3390/biomedicines12112604
Chicago/Turabian Style
Watanabe, Megumi, Tatsuya Sato, Toshiyuki Yano, Megumi Higashide, Toshifumi Ogawa, Nami Nishikiori, Masato Furuhashi, and Hiroshi Ohguro.
2024. "mTOR Inhibitors Modulate the Biological Nature of TGF-β2-Treated or -Untreated Human Trabecular Meshwork Cells in Different Manners" Biomedicines 12, no. 11: 2604.
https://doi.org/10.3390/biomedicines12112604
APA Style
Watanabe, M., Sato, T., Yano, T., Higashide, M., Ogawa, T., Nishikiori, N., Furuhashi, M., & Ohguro, H.
(2024). mTOR Inhibitors Modulate the Biological Nature of TGF-β2-Treated or -Untreated Human Trabecular Meshwork Cells in Different Manners. Biomedicines, 12(11), 2604.
https://doi.org/10.3390/biomedicines12112604
